StonvexLoading…
StonvexCore line items from OI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.43B | $6.53B | $7.11B | $6.86B |
Operating Income | $-49.00M | $38.00M | $67.00M | $805.00M |
Net Income | $-129.00M | $-106.00M | $-103.00M | $584.00M |
EPS (Diluted) | $-0.84 | $-0.69 | $-0.67 | $3.67 |
Total Assets | $9.24B | $8.65B | $9.67B | $9.06B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $759.00M | $734.00M | $913.00M | $773.00M |
Free Cash Flow OCF − CapEx | $168.00M | $-128.00M | $130.00M | $-385.00M |
Shares Outstanding | 153.55M | 154.55M | 154.65M | 158.99M |